Activity

Filter

Cancel
Date Panel Item Activity
7 actions
Severe Combined Immunodeficiency (absent T present B cells) v1.9 TP63 Zornitza Stark Marked gene: TP63 as ready
Severe Combined Immunodeficiency (absent T present B cells) v1.9 TP63 Zornitza Stark Gene: tp63 has been classified as Green List (High Evidence).
Severe Combined Immunodeficiency (absent T present B cells) v1.9 TP63 Zornitza Stark Phenotypes for gene: TP63 were changed from lymphopaenia to Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3, MIM# 604292; lymphopaenia
Severe Combined Immunodeficiency (absent T present B cells) v1.8 TP63 Zornitza Stark Classified gene: TP63 as Green List (high evidence)
Severe Combined Immunodeficiency (absent T present B cells) v1.8 TP63 Zornitza Stark Gene: tp63 has been classified as Green List (High Evidence).
Severe Combined Immunodeficiency (absent T present B cells) v1.7 TP63 Zornitza Stark reviewed gene: TP63: Rating: GREEN; Mode of pathogenicity: None; Publications: 39364398; Phenotypes: Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3, MIM# 604292; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Severe Combined Immunodeficiency (absent T present B cells) v1.6 TP63 Peter McNaughton gene: TP63 was added
gene: TP63 was added to Severe Combined Immunodeficiency (absent T present B cells). Sources: Literature
Mode of inheritance for gene: TP63 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Publications for gene: TP63 were set to doi: 10.3389/fimmu.2024.1438383
Phenotypes for gene: TP63 were set to lymphopaenia
Review for gene: TP63 was set to GREEN
Added comment: Multiple patients presenting with T cell lymphopaenia, potentially identified on SCID new born screening. T cell lymphopaenia due to thymic defect rather than intrinsic T cell defect so treatment is with thymic transplant rather than HSCT. Should be included in SCID panel as identification of this gene defect in lymphopaenic patients identified on SCID NBS will change treatment pathway dramatically.
Sources: Literature